How is the Bristol-Myers Squibb Co. today?

The Bristol-Myers Squibb Co. today is trading in the down by -0.06% at 46.65.

How has Bristol-Myers Squibb Co. performed historically?

The Bristol-Myers Squibb Co. is currently trading down -0.06% on an intraday basis in the past week the index fell -0.41%. The index has been down -21.21% in the past quarter and rose 9.76% in the past year. You can view this in the overview section.

What is Bristol-Myers Squibb Co. Annual Revenue?

Bristol-Myers Squibb Co. Annual Revenue rose 7.32%, in the last year to $48,300 M. Its sector's average revenue growth for the last fiscal year was 8.76%.

What is Bristol-Myers Squibb Co. Annual Net Profit?

Bristol-Myers Squibb Co. Annual Net Profit fell 211.5% in the last year to $8,948 M. Its sector's average net profit growth for the last fiscal year was -14.06%.

What is Bristol-Myers Squibb Co. Price to Earning Ratio?

Bristol-Myers Squibb Co. Price to Earning Ratio is 17.52, higher than its sector PE ratio of 4.56.

What is Bristol-Myers Squibb Co. Stock Price?

Bristol-Myers Squibb Co. Stock Price rose 9.76% and underperformed its sector by 37.12% in the past year.

What is Bristol-Myers Squibb Co. Quarterly Revenue?

Bristol-Myers Squibb Co. Quarterly Revenue fell 5.6% YoY to $11,201 M. Its sector's average revenue growth YoY for the quarter was 3.14%.

What is Bristol-Myers Squibb Co. Quarterly Net profit?

Bristol-Myers Squibb Co. Quarterly Net profit rose 120.62% YoY to $2,456 M. Its sector's average net profit growth YoY for the quarter was -236.05%.

What is Bristol-Myers Squibb Co. Debt to Equity Ratio?

Bristol-Myers Squibb Co. Debt to Equity Ratio of 3.13 is higher than 1. This implies that company assets are financed through debt.

What is Bristol-Myers Squibb Co. Return on Equity(ROE)?

Bristol-Myers Squibb Co. Return on Equity(ROE) for the last financial year was -39.1%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Bristol-Myers Squibb Co. Mutual Fund Holding?

Bristol-Myers Squibb Co. Mutual Fund Holding decreased by 0.1% in the last quarter to 65.51.

What is Bristol-Myers Squibb Co. Promoter Share Holding?

Bristol-Myers Squibb Co. Promoter Share Holding decreased by 0.01% in the most recent quarter to 0.05%.

What is Bristol-Myers Squibb Co. Interest Coverage Ratio?

Bristol-Myers Squibb Co. Interest Coverage Ratio is -3.3, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Bristol-Myers Squibb Co. Institutional Holding?

Bristol-Myers Squibb Co. Institutional Holding remained the same in the last quarter at 81.36%.

Bristol-Myers Squibb Co. XNYS: BMY

Bristol-Myers Squibb Co. Live Share Price Today, Share Analysis and Chart

Name: Bristol-Myers Squibb Co.: Is Infosys Ltd. worth buying?
Item: Bristol-Myers Squibb Co.
Rating: 2.471889
Author: Trendlyne DVM scores

Value Stock, Under Radar

about

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol deriv...

46.65 -0.03 (-0.06%)

26.34% Fall from 52W High

7.3M

XNYS Volume

XNYS 26 Jun, 2025 5:30 PM (EDT)

Dividend

Bristol-Myers Squibb Co. has an upcoming dividend of $0.62 per share due on 03 Jul 2025 See details

High Financial Strength

55.6 / 100

Affordable Valuation

56.5 / 100

Technically Bearish

30.1 / 100

Value Stock, Under Radar These stocks are strong in quality and valuation, but score weak in technical aspects. Hence, it is better to wait for the stock to change their momentum. View Similar Embed DVM

1Yr Price target upside is 22%

22 analysts

Bristol-Myers Squibb Co. Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Bristol-Myers Squibb Co. Live Share Price Today, Share Analysis and Chart

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol deriv...

26.34% Fall from 52W High

SWOT Analysis

Bristol-Myers Squibb Co. Live Price Chart

Bristol-Myers Squibb Co. FAQ

How is Bristol-Myers Squibb Co. today?

Bristol-Myers Squibb Co. today is trading in the red, and is down by -0.06% at 46.65.

How has Bristol-Myers Squibb Co. performed historically?

Bristol-Myers Squibb Co. is currently trading down -0.06% on an intraday basis. In the past week the stock fell -0.41%. stock has been down -21.21% in the past quarter and rose 9.76% in the past year. You can view this in the overview section.